MRNA - Moderna, Inc. - SEC Form 4 Insider Trading Screener
100 results - 
- 
- 
- 
- 
- 
- - - - - | TC | cnt | 1d | 1w | 1m | 6m |
X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Insider Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2020-10-23 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $70.01 | -20,000 | 1,910,646 | -1% | -$1,400,278 | |||||
| D | 2020-10-26 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $70.00 | -15,000 | 0 | -100% | -$1,050,004 | |||||
2020-10-23 | MRNA | Bancel Stephane | CEO | S - Sale | $70.01 | -11,046 | 23,747,131 | 0% | -$773,358 | ||||||
| D | 2020-10-21 | MRNA | Henderson Lori M. | GC, Secretary | S - Sale+OE | $70.16 | -32,000 | 681 | -98% | -$2,245,158 | |||||
| M | 2020-10-21 | MRNA | Bancel Stephane | CEO | S - Sale | $69.87 | -19,000 | 23,758,177 | 0% | -$1,327,590 | |||||
2020-10-20 | MRNA | Bancel Stephane | CEO | S - Sale | $72.05 | -8,455 | 23,778,177 | 0% | -$609,183 | ||||||
| D | 2020-10-19 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $71.94 | -15,000 | 0 | -100% | -$1,079,025 | |||||
2020-10-16 | MRNA | Bancel Stephane | CEO | S - Sale | $75.02 | -11,046 | 23,786,632 | 0% | -$828,618 | ||||||
| M | 2020-10-14 | MRNA | Bancel Stephane | CEO | S - Sale | $77.53 | -19,000 | 23,797,678 | 0% | -$1,473,090 | |||||
| DM | 2020-10-12 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $76.08 | -20,000 | 1,920,646 | -1% | -$1,521,688 | |||||
| D | 2020-10-12 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $74.47 | -15,000 | 0 | -100% | -$1,117,049 | |||||
| M | 2020-10-09 | MRNA | Bancel Stephane | CEO | S - Sale | $73.26 | -19,265 | 23,453,144 | 0% | -$1,411,259 | |||||
| M | 2020-10-07 | MRNA | Bancel Stephane | CEO | S - Sale | $72.42 | -19,000 | 23,836,943 | 0% | -$1,376,070 | |||||
| D | 2020-10-05 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $70.24 | -15,000 | 0 | -100% | -$1,053,645 | |||||
| DM | 2020-10-02 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $68.68 | -20,000 | 1,930,646 | -1% | -$1,373,600 | |||||
2020-10-02 | MRNA | Bancel Stephane | CEO | S - Sale | $70.64 | -11,046 | 23,856,943 | 0% | -$780,251 | ||||||
| M | 2020-09-30 | MRNA | Bancel Stephane | CEO | S - Sale | $70.60 | -27,481 | 14,765,374 | 0% | -$1,940,203 | |||||
| D | 2020-09-28 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $70.28 | -17,197 | 0 | -100% | -$1,208,549 | |||||
2020-09-25 | MRNA | Bancel Stephane | CEO | S - Sale | $68.49 | -11,046 | 23,896,470 | 0% | -$756,519 | ||||||
| DM | 2020-09-23 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $66.72 | -20,000 | 1,930,646 | -1% | -$1,334,311 | |||||
| M | 2020-09-23 | MRNA | Bancel Stephane | CEO | S - Sale | $66.68 | -19,000 | 23,907,516 | 0% | -$1,266,910 | |||||
| D | 2020-09-21 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $67.30 | -20,000 | 0 | -100% | -$1,345,953 | |||||
| M | 2020-09-18 | MRNA | Bancel Stephane | CEO | S - Sale | $68.08 | -19,633 | 23,529,844 | 0% | -$1,336,626 | |||||
| M | 2020-09-16 | MRNA | Bancel Stephane | CEO | S - Sale | $68.10 | -19,000 | 23,947,149 | 0% | -$1,293,810 | |||||
| D | 2020-09-14 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $62.66 | -20,034 | 0 | -100% | -$1,255,321 | |||||
| D | 2020-09-14 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $61.42 | -20,000 | 1,940,646 | -1% | -$1,228,468 | |||||
2020-09-11 | MRNA | Bancel Stephane | CEO | S - Sale | $58.42 | -11,046 | 23,967,149 | 0% | -$645,259 | ||||||
| M | 2020-09-09 | MRNA | Bancel Stephane | CEO | S - Sale | $56.56 | -26,030 | 16,213,315 | 0% | -$1,472,319 | |||||
| D | 2020-09-08 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $56.20 | -26,467 | 0 | -100% | -$1,487,355 | |||||
2020-09-04 | MRNA | Bancel Stephane | CEO | S - Sale | $61.87 | -11,046 | 24,005,225 | 0% | -$683,459 | ||||||
| D | 2020-09-03 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $65.65 | -10,000 | 1,950,646 | -1% | -$656,500 | |||||
2020-09-03 | MRNA | Bancel Stephane | CEO | S - Sale | $65.65 | -10,000 | 24,016,271 | 0% | -$656,500 | ||||||
| D | 2020-09-02 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $62.89 | -10,000 | 1,950,646 | -1% | -$628,900 | |||||
| M | 2020-09-01 | MRNA | Bancel Stephane | CEO | S - Sale | $63.22 | -18,247 | 24,026,271 | 0% | -$1,153,564 | |||||
| D | 2020-08-31 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $64.10 | -30,000 | 0 | -100% | -$1,922,950 | |||||
2020-08-28 | MRNA | Bancel Stephane | CEO | S - Sale | $66.69 | -11,046 | 24,045,518 | 0% | -$736,640 | ||||||
| M | 2020-08-26 | MRNA | Bancel Stephane | CEO | S - Sale | $68.74 | -19,000 | 24,056,564 | 0% | -$1,306,150 | |||||
| D | 2020-08-24 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $64.99 | -20,000 | 1,950,646 | -1% | -$1,299,703 | |||||
| D | 2020-08-24 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $64.99 | -25,000 | 0 | -100% | -$1,624,671 | |||||
2020-08-21 | MRNA | Bancel Stephane | CEO | S - Sale | $66.69 | -11,046 | 24,076,564 | 0% | -$736,640 | ||||||
| M | 2020-08-19 | MRNA | Bancel Stephane | CEO | S - Sale | $67.46 | -27,824 | 14,951,650 | 0% | -$1,876,927 | |||||
| D | 2020-08-17 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $69.06 | -20,000 | 0 | -100% | -$1,381,200 | |||||
2020-08-14 | MRNA | Bancel Stephane | CEO | S - Sale | $68.98 | -11,046 | 24,066,424 | 0% | -$761,991 | ||||||
| M | 2020-08-12 | MRNA | Bancel Stephane | CEO | S - Sale | $72.22 | -19,000 | 24,077,470 | 0% | -$1,372,160 | |||||
| M | 2020-08-12 | MRNA | Bancel Stephane | CEO | S - Sale | $72.22 | -19,000 | 24,077,470 | 0% | -$1,372,160 | |||||
| DM | 2020-08-12 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $69.03 | -20,000 | 1,960,646 | -1% | -$1,380,659 | |||||
| D | 2020-08-10 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $74.27 | -20,000 | 0 | -100% | -$1,485,400 | |||||
| M | 2020-08-07 | MRNA | Bancel Stephane | CEO | S - Sale | $74.23 | -19,143 | 23,633,522 | 0% | -$1,421,031 | |||||
| M | 2020-08-05 | MRNA | Bancel Stephane | CEO | S - Sale | $76.61 | -19,000 | 24,116,613 | 0% | -$1,455,610 | |||||
| D | 2020-08-03 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $74.89 | -20,000 | 1,970,646 | -1% | -$1,497,800 | |||||
| D | 2020-08-03 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $74.89 | -20,000 | 0 | -100% | -$1,497,800 | |||||
| M | 2020-07-31 | MRNA | Bancel Stephane | CEO | S - Sale | $75.15 | -19,143 | 23,661,619 | 0% | -$1,438,545 | |||||
| M | 2020-07-29 | MRNA | Bancel Stephane | CEO | S - Sale | $79.88 | -19,000 | 24,155,756 | 0% | -$1,517,800 | |||||
| D | 2020-07-27 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $78.73 | -20,000 | 0 | -100% | -$1,574,524 | |||||
| DM | 2020-07-23 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $78.86 | -20,000 | 1,970,646 | -1% | -$1,577,102 | |||||
| DM | 2020-07-23 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $78.86 | -20,000 | 1,970,646 | -1% | -$1,577,102 | |||||
2020-07-24 | MRNA | Bancel Stephane | CEO | S - Sale | $71.56 | -11,046 | 24,175,756 | 0% | -$790,461 | ||||||
| M | 2020-07-22 | MRNA | Bancel Stephane | CEO | S - Sale | $80.98 | -19,000 | 24,186,802 | 0% | -$1,538,690 | |||||
| D | 2020-07-20 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $83.50 | -20,000 | 0 | -100% | -$1,669,956 | |||||
| M | 2020-07-17 | MRNA | Bancel Stephane | CEO | S - Sale | $86.48 | -17,372 | 23,709,716 | 0% | -$1,502,402 | |||||
| M | 2020-07-15 | MRNA | Bancel Stephane | CEO | S - Sale | $83.92 | -19,000 | 24,224,174 | 0% | -$1,594,460 | |||||
| D | 2020-07-15 | MRNA | Nabel Elizabeth G | Dir | S - Sale+OE | $87.84 | -73,975 | 0 | -100% | -$6,497,964 | |||||
| D | 2020-07-13 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $69.92 | -10,000 | 1,980,646 | -1% | -$699,237 | |||||
| A | 2020-03-13 | MRNA | Hoge Stephen | Pres | S - Sale | $22.43 | -1,110 | 2,046,733 | 0% | -$24,897 | |||||
| D | 2020-07-13 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $69.94 | -20,000 | 0 | -100% | -$1,398,744 | |||||
2020-07-10 | MRNA | Bancel Stephane | CEO | S - Sale | $63.85 | -20,281 | 15,076,870 | 0% | -$1,294,972 | ||||||
2020-07-09 | MRNA | Bancel Stephane | CEO | S - Sale | $62.04 | -10,000 | 24,264,455 | 0% | -$620,400 | ||||||
| DM | 2020-07-07 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $59.73 | -82,688 | 0 | -100% | -$4,939,096 | |||||
2020-07-06 | MRNA | Bancel Stephane | CEO | S - Sale | $59.53 | -11,046 | 24,275,455 | 0% | -$657,576 | ||||||
| D | 2020-07-06 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $58.48 | -10,000 | 1,980,656 | -1% | -$584,800 | |||||
| D | 2020-07-02 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $59.94 | -10,000 | 1,980,656 | -1% | -$599,400 | |||||
2020-07-02 | MRNA | Bancel Stephane | CEO | S - Sale | $59.94 | -10,000 | 24,287,501 | 0% | -$599,400 | ||||||
2020-07-01 | MRNA | Bancel Stephane | CEO | S - Sale | $62.92 | -18,344 | 24,297,501 | 0% | -$1,154,204 | ||||||
| D | 2020-06-30 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $64.00 | -39,752 | 0 | -100% | -$2,544,294 | |||||
2020-06-26 | MRNA | Bancel Stephane | CEO | S - Sale | $60.65 | -11,046 | 24,315,845 | 0% | -$669,892 | ||||||
2020-06-25 | MRNA | Bancel Stephane | CEO | S - Sale | $67.00 | -10,000 | 24,326,891 | 0% | -$670,000 | ||||||
| D | 2020-06-23 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $63.71 | -39,752 | 0 | -100% | -$2,532,720 | |||||
| M | 2020-06-23 | MRNA | Hoge Stephen | Pres | S - Sale | $64.24 | -10,000 | 1,980,656 | -1% | -$642,444 | |||||
2020-06-24 | MRNA | Bancel Stephane | CEO | S - Sale | $63.25 | -9,000 | 24,336,891 | 0% | -$569,250 | ||||||
2020-06-22 | MRNA | Bancel Stephane | CEO | S - Sale | $65.92 | -4,521 | 24,346,891 | 0% | -$298,024 | ||||||
2020-06-19 | MRNA | Bancel Stephane | CEO | S - Sale | $64.61 | -11,046 | 24,351,412 | 0% | -$713,715 | ||||||
| D | 2020-06-18 | MRNA | Henderson Lori M. | GC, Secretary | S - Sale+OE | $63.03 | -64,000 | 681 | -99% | -$4,033,920 | |||||
| D | 2020-06-16 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $63.76 | -39,752 | 0 | -100% | -$2,534,618 | |||||
| M | 2020-06-12 | MRNA | Hoge Stephen | Pres | S - Sale | $63.32 | -10,000 | 1,990,656 | 0% | -$633,219 | |||||
2020-06-12 | MRNA | Bancel Stephane | CEO | S - Sale | $61.64 | -11,046 | 24,362,458 | 0% | -$680,849 | ||||||
2020-06-10 | MRNA | Bancel Stephane | CEO | S - Sale | $58.80 | -3,435 | 24,373,504 | 0% | -$201,978 | ||||||
| D | 2020-06-09 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $58.47 | -39,752 | 0 | -100% | -$2,324,364 | |||||
2020-06-05 | MRNA | Bancel Stephane | CEO | S - Sale | $57.85 | -11,046 | 24,376,939 | 0% | -$639,056 | ||||||
| AM | 2020-05-29 | MRNA | Bancel Stephane | CEO | S - Sale | $59.44 | -15,924 | 23,813,577 | 0% | -$946,591 | |||||
| A | 2020-05-12 | MRNA | Nabel Elizabeth G | Dir | S - Sale | $66.00 | -30,000 | 14,344 | -68% | -$1,980,000 | |||||
| A | 2020-05-20 | MRNA | Henderson Lori M. | GC, Secretary | S - Sale | $70.00 | -64,000 | 0 | -100% | -$4,480,000 | |||||
| A | 2020-05-05 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale | $50.48 | -4,770 | 0 | -100% | -$240,790 | |||||
| A | 2020-05-19 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale | $78.16 | -125,044 | 0 | -100% | -$9,773,439 | |||||
| A | 2020-05-26 | MRNA | Hoge Stephen | Pres | S - Sale | $66.11 | -200 | 1,996,540 | 0% | -$13,222 | |||||
| A | 2020-05-01 | MRNA | Andres Juan | See remarks | S - Sale | $49.69 | -3,934 | 0 | -100% | -$195,480 | |||||
| A | 2020-05-13 | MRNA | Andres Juan | See remarks | S - Sale | $66.89 | -1,300 | 0 | -100% | -$86,957 | |||||
| A | 2020-05-15 | MRNA | Kim Lorence H. | CFO | S - Sale | $63.80 | -2,600 | 1,219,910 | 0% | -$165,880 | |||||
| A | 2020-05-20 | MRNA | Bancel Stephane | CEO | S - Sale | $70.00 | -12,558 | 9,198,717 | 0% | -$879,060 | |||||
| D | 2020-06-02 | MRNA | Kim Lorence H. | CFO | S - Sale+OE | $58.30 | -241,000 | 1,202,510 | -17% | -$14,050,300 | |||||
| D | 2020-06-02 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $58.32 | -98,956 | 0 | -100% | -$5,771,275 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |